• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,577
    Total Members
    3,093
    Most Online
    Dr Susan Lockman
    Newest Member
    Dr Susan Lockman
    Joined
  • 0

    Weaker Bones, More Fractures for Celiac Disease Patients


    Jefferson Adams

    Celiac.com 03/11/2011 - At the December 2010 Annual Conference of the Endocrine Society of India (ESICON), Dr. Ameya Joshi presented a paper on the reduced bone density, and elevated risk of bone fracture faced by people with both celiac disease and type 1 diabetes. The paper was awarded second prize among conference presentations.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    Dr. Joshi's research was conducted under the auspices of the endocrinology department of BYL Nair Hospital, and the supervision of department head, Premlata Varthakavi.

    In his recent study, Dr. Joshi found that people with both celiac disease and type 1 diabetes have been found to have poor bone mineral density, making them susceptible to fractures.

    For his study, Dr. Joshi's research team tested 80 type 1 diabetics. They found that 11 of the 80 patients had celiac disease.

    A control group of 22 patients suffered from type 1 diabetes without celiac disease. Patient ranged in age from 12 years to 40 years.

    “While many suffer from typical symptoms such as gastrointestinal problems, others suffer from fractures from unrecognized trauma,” said Dr Joshi, adding, “Simple dietary measures can reverse these symptoms and improve bone density.”

    While similar research has been done in the West, this is the first study by an Indian research team to show a correlation between celiac disease and low bone mineral density in type 1 diabetics.

    0


    User Feedback

    Recommended Comments

    Guest Diane Aragon

    Posted

    I have poor mineral density and have just found out that I have celiac disease and am 68 years old. I have no other symptoms except osteopororis. I have tried the gluten free diet and it caused me to feel bloated and very gassy. I have now gone off the diet and feel much better. My daughter has celiac and has all of the symptoms and has to be on the diet.

    Share this comment


    Link to comment
    Share on other sites
    Guest Haley

    Posted

    I have poor mineral density and have just found out that I have celiac disease and am 68 years old. I have no other symptoms except osteopororis. I have tried the gluten free diet and it caused me to feel bloated and very gassy. I have now gone off the diet and feel much better. My daughter has celiac and has all of the symptoms and has to be on the diet.

    Diane, if you are a celiac and don't follow the diet your chances for a GI cancer increase greatly. Of course that is your decision.

    Share this comment


    Link to comment
    Share on other sites


    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    Jefferson Adams is a freelance writer living in San Francisco. He has covered Health News for Examiner.com, and provided health and medical content for Sharecare.com. His work has appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate, among others.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   6 Members, 0 Anonymous, 376 Guests (See full list)

  • Related Articles

    Scott Adams
    Arch Intern Med. 2005;165:370-372, 393-399
    Celiac.com 03/09/2005 - According to a new study by researchers at Washington University School of Medicine in St. Louis, Missouri, everyone with osteoporosis should also be screened for celiac disease. The study looked at 840 people—266 with osteoporosis and 574 without—who were screened for celiac disease using serum anti-tissue transglutaminase (tTG) and anti-endomysial (EMA) antibodies—those who tested positive for either were given a follow-up biopsy. The serological screening results indicated that 12 (4.5%) of the 266 osteoporotic patients were positive for celiac disease, while only six (1.0%) of the 574 non-osteoporotic patients tested positive. Out of the osteoporotic patients who were positive, 3.4% were confirmed by a biopsy, while only 0.2% of the non-osteoporotic patients were confirmed via biopsy (2 of the serological positive group refused a follow-up biopsy). In the group with both celiac disease and osteoporosis, the researchers found a direct correlation between the severity of both diseases, and the treatment of these patients via a gluten-free diet dramatically improved the symptoms of both diseases.
    According to the researchers: The prevalence of celiac disease among osteoporotic patients was much higher than among the non-osteoporotic population and high enough to justify a recommendation that all individuals with osteoporosis undergo serologic screening for celiac disease.

    Scott Adams
    International Osteoporosis Foundation and National Osteoporosis Foundation 2005 - Received: 31 March 2004 / Accepted: 30 November, 2004 / Published online: 4 February 2005. Michael W. Davie, I. Gaywood, E. George, P.W. Jones, T. Masud, T. Price, G.D. Summers. International Osteoporosis Foundation and National Osteoporosis Foundation 2005 - Received: 31 March 2004 / Accepted: 30 November, 2004 / Published online: 4 February 2005. Celiac.com 04/27/2006 - Because recent studies may have underestimated the association of celiac disease with fracture by studying patients with low fracture risk, doctors recently conducted a more comprehensive survey of celiac and non-celiac patients.
    Their study of post-menopausal women over age 50 concluded that women diagnosed with celiac disease face an increased risk of fracture over time compared with control groups. The study looked at non-spinal fracture risk associated with celiac patients and non-celiac control groups in relation to the time-periods before and after the diagnosis of celiac disease.
    According to the study, Celiac patients displayed greater fracture prevalence (odds ratio [OR], 1.51), confidence interval [CI], 1.13:2.02) and fracture after 50 years (OR, 2.20; CI, 1.49:3.25). The study compared Three hundred and eighty-three female celiac patients with 445 female controls, all over 50 years old. The mean age of celiacs tested was 61.4-67.8 years, and 62.7-69.9 years in controls. The celiac patients generally weighed less than the control patients of the same height.
    Among celiac patients diagnosed after age 50, no excess fracture risk was found in the period more than 10 years before diagnosis, but risk increased in the period from 10 years before diagnosis to 5 years after and remained high more than 5 years after diagnosis (p
    Adjusted for height and weight, instance of wrist fracture between the groups was about the same, but celiacs did have more multiple fractures (OR, 2.96; CI, 1.81:4.83). Further, while women diagnosed before age fifty, showed no excess fracture risk, those celiac patients more than five years beyond their diagnosis faced increased risk of wrist fractures ( p
    While women diagnosed with celiac disease before age 50 faced no greater risk than their non-celiac peers, for those diagnosed after age fifty, the risk of fracture increases as the years pass, with the greatest statistical increase occurring five to ten years after a diagnosis.
    Accordingly, thin women over 50 who suffer from multiple fractures should consider being tested for celiac disease. If the diagnosis is positive, they should take measures to ensure proper calcium and vitamin D intake.

    Jefferson Adams
    Celiac.com 07/01/2011 - People with celiac disease, who otherwise have no risk for osteoporosis, face a risk of developing progressive bone loss that is more than four times higher than the general population. This according to a study by the researchers from the Lancaster University School of Health and Medicine in the UK.
    In the latest study, the team took bone mass density readings of participants' skeletal health using dual-energy x-ray absorptiometry scans. They did this for more than 1,000 adults with celiac disease. The results showed that the lumbar vertebrae of individuals with celiac disease showed significantly lower bone density than those of healthy individuals. The team announced their findings at the European League Against Rheumatism's 2011 Annual Congress.
    No subject in the study had other risk factors for bone loss, and the team concluded that celiac disease increased the prospect of osteoporosis by a factor of four and a half, even among otherwise healthy adults.
    Because lumbar vertebrae sit at the base the spinal column, they take the most pressure, and thus, a more likely place for osteoporosis-related fractures.
    In the U.S., vertebral pressure fractures are the most common skeletal injury caused by progressive bone loss. Over a half a million vertebral pressure fractures occur each year, according to the National Osteoporosis Foundation.
    The UK study just the latest to show a connection between celiac disease and poor bone health. A 2010 report from Canada's University of Alberta that the average child with gluten allergies got less than half the amount of required vitamin K, as well as too little vitamin D.
    The research team suggests that dietary supplements may improve nutrition in children with celiac disease, and thus reduce the likelihood that they will develop osteoporosis.
    Source:

    endocrineweb.com

    Jefferson Adams
    Celiac.com 12/15/2014 - Non-celiac gluten sensitivity (NCGS), aka `wheat sensitivity’ (NCWS), is currently included in the spectrum of gluten-related disorders. 
    Many people with celiac disease suffer from low bone mass density, but there has been no good data on low bone mass density in people with NCWS.
    A team of researchers recently set out to determine rates of low bone mass density in NCWS patients and to search for correlations with other clinical characteristics. The researchers included Antonio Carroccio, Maurizio Soresi, Alberto D'Alcamo, Carmelo Sciumè, Giuseppe Iacono, Girolamo Geraci, Ignazio Brusca, Aurelio Seidita, Floriana Adragna, Miriam Carta and Pasquale Mansueto.
    For their prospective observation study, the team assessed 75 NCWS patients (63 women; median age 36 years) with irritable bowel syndrome (IBS)-like symptoms, along with control groups of 65 patients with IBS and 50 with celiac disease. The team recruited patients from two Internal Medicine Departments. The diagnoses of NCWS were established using an elimination diet and double-blind placebo controlled wheat challenge.
    The team determined bone mass density in all subjects using Dual Energy X-Ray Absorptiometry (DXA), in addition to assessing all subjects for duodenal histology, HLA DQ typing, body mass index, and daily calcium intake. The double-blind placebo controlled wheat challenge revealed that 30 of the 75 NCWS patients suffered sensitivity to multiple foods. Osteopenia and osteoporosis frequency increased from IBS to NCWS and to celiac disease (P <0.0001).
    Thirty-five of the patients with NCWS (46.6%) showed osteopenia or osteoporosis. Low bone mass density was related to low body mass index and multiple food sensitivity. Levels of daily dietary calcium intake were significantly lower in NCWS patients than in control subjects with IBS.
    The study showed that patients with NCWS suffered from higher rates of bone mass loss; which correlated with low body mass index, and was more frequent in NCWS patients who showed sensitivity to multiple foods.
    The team also found that patients with NCWS generally had a low daily intake of dietary calcium.
    Source: 
    BMC Medicine 2014, 12:230. doi:10.1186/s12916-014-0230-2

  • Recent Articles

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.

    Jefferson Adams
    Celiac.com 06/16/2018 - Summer is the time for chips and salsa. This fresh salsa recipe relies on cabbage, yes, cabbage, as a secret ingredient. The cabbage brings a delicious flavor and helps the salsa hold together nicely for scooping with your favorite chips. The result is a fresh, tasty salsa that goes great with guacamole.
    Ingredients:
    3 cups ripe fresh tomatoes, diced 1 cup shredded green cabbage ½ cup diced yellow onion ¼ cup chopped fresh cilantro 1 jalapeno, seeded 1 Serrano pepper, seeded 2 tablespoons lemon juice 2 tablespoons red wine vinegar 2 garlic cloves, minced salt to taste black pepper, to taste Directions:
    Purée all ingredients together in a blender.
    Cover and refrigerate for at least 1 hour. 
    Adjust seasoning with salt and pepper, as desired. 
    Serve is a bowl with tortilla chips and guacamole.